Drug intelligence / Profile preview

dextromethorphan + chlorpheniramine maleate + guaifenesin

Development stage
Unknown
Lead developer
Genexa
Modality
Small Molecules
Administration
Oral
01

Overview

**Dextromethorphan + chlorpheniramine maleate + guaifenesin** is a fixed-dose, multi-ingredient over-the-counter (OTC) medication used primarily for temporary relief of symptoms associated with the common cold, including cough, congestion, runny nose, sneezing, itchy nose, and itchy or watery eyes[1][5]. The mechanism of action is multifactorial: - **Dextromethorphan** is a centrally acting cough suppressant that reduces the urge to cough by acting on the brain’s cough center[1][5]. - **Chlorpheniramine maleate** is a first-generation antihistamine that blocks histamine receptors, thus alleviating allergy symptoms such as runny nose, sneezing, itchy nose, and watery eyes[1][5]. - **Guaifenesin** is an expectorant that increases hydration of respiratory tract secretions, thinning mucus and making it easier to clear from the airways[1][5]. This combination is intended for both adults and children, though age restrictions and dosing should follow product labeling and medical advice. Common side effects include drowsiness, dizziness, dry mouth, nausea, and headache[5].

Brand names
Kids Cough Daytime Nighttime Combo
02

Targets

SERT (Sodium-dependent serotonin transporter)HRH1 (Histamine H1 Receptor)SIGMAR1 (Sigma non-opioid intracellular receptor 1)Nicotinic Acetylcholine ReceptorNMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on dextromethorphan + chlorpheniramine maleate + guaifenesin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextromethorphan + chlorpheniramine maleate + guaifenesin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call